testo-alternativo
Vaccines at the Edge: Who’s Really Protected?

Pediatric Frontiers: Weekly Insights

Pediatria

Vaccines at the Edge: Who’s Really Protected?

Despite global immunization campaigns, massive gaps remain for the most vulnerable children. This episode dives into emerging research on vaccine inequities, hesitancy, and cutting-edge innovations that could redefine protection worldwide.

Login or Register to listen to this episode

Bibliography

- Daigle D et al. Recommendations for pneumococcal vaccination of at-risk children: a global overview (2022-2024). Vaccine. 2025;63:127669.


- Wang Y et al. Mpox: disease manifestations and therapeutic development. J Virol. 2025;99:e0015225.


- Chalmers JD et al. Neutrophil-derived biomarkers in bronchiectasis: identifying a common therapeutic target. Eur Respir J. 2025;66:2500081.


- Locatelli G et al. Determinants and motivations of vaccination hesitancy and uptake in nurses: systematic review and meta-analysis. J Clin Nurs. 2025;34:4005-4037.


- Christie CDC. Resurgence of pertussis: whopping the '100-day cough'. Curr Opin Pediatr. 2025;37:508-516.


- Wong LP et al. Addressing male HPV vaccination in China: challenges and opportunities. Hum Vaccin Immunother. 2025;21:2552061.


- Pichon S et al. Safety and immunogenicity of a pneumococcal conjugate vaccine with routine pediatric vaccines in healthy infants and toddlers. Pediatr Infect Dis J. 2025;44:995-1008.


- Murphy S et al. Global variations in immunisation strategies against pertussis in infancy. Expert Rev Vaccines. 2025;24:882-903.


- Tran BT et al. Hematopoietic stem and progenitor cells as a reservoir for trained immunity. Elife. 2025;14:e106610.


- Pawłuszkiewicz K et al. Advances in the diagnosis and treatment of rotavirus infections: narrative review. Int J Mol Sci. 2025;26:9175.

Comments

Please Login to leave a comment.

No comments yet. Be the first to comment!